Tizanidne Hydrochloride Capsule
Product Images NDC 63629-8873

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 63629-8873). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636298873)

Tizanidine Hydrochloride Capsules is a prescription medication. Each capsule includes 6.87 mg of tizanidine hydrochloride, which is equal to 6 mg of tizanidine base. To prevent accidental ingestion, it should be kept out of the reach of children. It must be stored at a temperature between 15° to 30°C, and must be dispensed in a tight container as described in the USP. These capsules are not interchangeable with tizanidine tablets or Zanaflex tablets. The National Drug Code or NDC code for this medication is 63629-8873-1.*

FDA Label Image

Tiz01 (Tiz01)

FDA Label Image

Tiz02 (Tiz02)

FDA Label Image

Tiz03 (Tiz03)

FDA Label Image

Tiz04 (Tiz04)

This text suggests that there was a study conducted on the effect of tizanidine, with a mean dose of 26.8 mg, on the Ashworth Score. The Ashworth Score is a measure of spasticity in patients with neurological conditions. The study had a titration period of 3 weeks and a maintenance period of 7 weeks. The results showed an improvement in the Ashworth Score.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.